For the Inventor, By the Inventor

Enter assignee name

Duluth, GA, United States of America

Merial Limited

Calculating rank

USPTO Granted Patents = 321

% Expired Patents = 6.9

CIPO Patents = 60

EPO Patents = 188

Trademarks = 52

Forward Citations = 1,776

Loading Chart...

Loading Chart...

435 inventors (with patents filed for the assignee):

Jean-Christophe Francis Audonnet (43 out of 52 patents)

Mark Soll (23 out of 28 patents)

Charles Q Meng (20 out of 29 patents)

4. Jules Maarten Minke (17 out of 20 patents)

5. Michel Joseph Bublot (17 out of 28 patents)

6. Michel Albert Riviere (16 out of 23 patents)

7. Loic Patrick Le Hir De Fallois (15 out of 29 patents)

8. Karl Seeger (15 out of 22 patents)

9. Hyoung Ik Lee (14 out of 27 patents)

10. Laurent Bernard Fischer (14 out of 16 patents)

11. Annabelle Bouchardon (13 out of 18 patents)

12. Stefan Schnatterer (12 out of 30 patents)

13. Michael Maier (12 out of 12 patents)

14. Philippe Jeannin (12 out of 14 patents)

15. Werner Knauf (12 out of 50 patents)

Core Competencies:

Parasiticidal Compounds

Vaccines

Antimicrobial Treatments

Isoxazoline Compounds

Anthelmintic Compositions

Recombinant Vaccines

Oral Health Methods

Vaccine Formulations

Topical Compositions

Cryopreservation

Adjuvants

Veterinary Compositions

321 patents: Sort by Forward Citations

1. 12653876 - M Hyo Multivalent Vaccine and Uses Thereof (2026-06-16),

2. 10857121 - Use of malononitrile compounds for protecting animals from parasites (2020-12-08),

3. 10433552 - Process for the preparation of isoxazoline compounds (2019-10-08),

4. 10251863 - Parasiticidal compositions comprising indole derivatives, methods and uses thereof (2019-04-09),

5. 10213509 - Reduced foaming vaccine compositions (2019-02-26),

6. 10206928 - Method of maintaining oral health in animals (2019-02-19),

7. 10188734 - Reduced foaming vaccine compositions (2019-01-29),

8. 10188721 - Recombinant adenovirus vectored FMDV vaccines and uses thereof (2019-01-29),

9. 10166188 - Method for vacuum-assisted preservation of biologics including vaccines (2019-01-01),

10. 10155725 - Anthelmintic compounds and compositions and method of using thereof (2018-12-18),

11. 10131744 - Antimicrobial polyamide compositions and mastitis treatment (2018-11-20),

12. 10098941 - [object Object] (2018-10-16),

13. 10081656 - Anthelmintic depsipeptide compounds (2018-09-25),

14. 10080798 - Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof (2018-09-25),

15. 10080791 - Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins (2018-09-25),

Company Overview

Merial Limited, headquartered in Duluth, GA, specializes in the development and manufacturing of innovative solutions for animal health. The company focuses on a range of core technologies, including parasiticidal compounds, vaccines, and antimicrobial treatments, aimed at improving the health and well-being of livestock and companion animals. With expertise in isoxazoline compounds and recombinant vaccines, Merial is committed to advancing veterinary medicine through research and development in oral health methods and vaccine formulations.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

321 Patents

#3 in Duluth, GA

#35 in Georgia

#1,379 in US

#2,808 in the World

Duluth, GA, United States of America

Merial Limited

Forward Citations = 1,776

435 inventors:

Jean-Christophe Francis Audonnet (43 out of 52 patents)

Mark Soll (23 out of 28 patents)

Charles Q Meng (20 out of 29 patents)

4. Jules Maarten Minke (17 out of 20 patents)

5. Michel Joseph Bublot (17 out of 28 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Merial Limited. Retrieved from https://idiyas.com/company/merial

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…